Acumen Pharmaceuticals, Inc. (ABOS)

6.70 +0.13 (+2.05%) As of 12:59PM EST. Market open.

Acumen Pharmaceuticals, Inc.

427 Park Street
Charlottesville, VA 22902
United States
434 297 1000
https://acumenpharm.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 14

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Daniel J. O'Connell M.B.A.	CEO, Pres & Director	801.62k	N/A	1971
Mr. Matt Zuga	CFO, Chief Bus. Officer & Corp. Sec.	679.27k	N/A	N/A
Dr. Eric Siemers M.D.	Chief Medical Officer	460.64k	N/A	1955
Mr. Russell Barton M.S.	Chief Operating Officer	N/A	N/A	1959
Mr. Derek M. Meisner Esq., J.D.	Chief Legal Officer	N/A	N/A	1971
Ms. Robyn Moxon M.A.	Mang. of Corp. & Clinical Communications	N/A	N/A	N/A
Ms. Julie Bockenstette	Exec. VP & Head of HR	N/A	N/A	N/A
Ms. Siew Tin Gan M.S.	Assistant VP & Head of Clinical Operations	N/A	N/A	N/A
Ms. Janice Hitchcock	VP & Head of Regulatory Affairs	N/A	N/A	N/A
Ms. Liean Schenck M.S.	VP & Head of CMC	N/A	N/A	N/A

Amounts are as of December 31, 2021 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Acumen Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for the treatment of Alzheimer's disease. The company focuses on advancing a targeted immunotherapy drug candidate ACU193, a humanized monoclonal antibody that is in Phase I clinical-stage to target soluble amyloid-beta oligomers. Acumen Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in Charlottesville, Virginia.

Corporate Governance

Acumen Pharmaceuticals, Inc.’s ISS Governance QualityScore as of January 28, 2023 is 7. The pillar scores are Audit: 8; Board: 6; Shareholder Rights: 8; Compensation: 8.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.